NCT06638229

Brief Summary

This study investigates the effectiveness of a specific electrotherapy treatment for individuals with chronic non-specific low back pain. The participants, who had low back pain for more than three months, were divided into two groups: a treatment group and a waitlist control group. The treatment group received electrotherapy using the StimaWELL 120MTRS system, which provided electrical stimulation and heat therapy to the entire spine over four weeks. The study assessed various outcomes, including pain levels, disability, and quality of life, before and after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
Last Updated

January 20, 2025

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

October 9, 2024

Last Update Submit

January 17, 2025

Conditions

Keywords

chronic low back painelectrotherapy

Outcome Measures

Primary Outcomes (1)

  • Pain Catastrophizing Scale

    Participants' pain catastrophizing levels were measured using the Pain Catastrophizing Scale (PCS). The total score of the PCS is 52, with higher scores indicating higher levels of catastrophizing behavior.

    Before and after 4 weeks of treatment

Secondary Outcomes (3)

  • Numeric Pain Scale

    Before and after 4 weeks of treatment

  • Oswestry Disability Index

    Before and after 4 weeks of treatment

  • Nottingham Health Profile

    Before and after 4 weeks of treatment

Study Arms (2)

StimaWell

EXPERIMENTAL

Participants in the StimaWELL group had previously received electrotherapy treatment for the entire spine for 4 weeks, 2 days a week. Before the treatment, participants were informed about their medical condition and the planned treatment. The StimaWELL 120MTRS system (StimaWELL® 120MTRS; Schwa-medico, Wetzlarer Straße 41-43, 35630 Ehringshausen, Germany) was used for the treatment and a stimulation mat was used to apply electrical stimulation along the entire back. The 12 channels of the mat provided different current intensities to different areas and the system offered programs tailored to various therapeutic goals.

Device: The StimaWELL 120MTRS system

Waitlist

NO INTERVENTION

Patients presenting to the clinic for treatment and waiting without intervention in the waitlist group after routine evaluation.

Interventions

A standardized current (dynamic deep wave stimulation) was applied to all patients. Additionally, the mat, which reached a temperature of 40°C, provided heat therapy with electrical stimulation

StimaWell

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old,
  • LBP for more than three months,
  • Pain of 3 or more according to the Numeric Pain Scale
  • being literate

You may not qualify if:

  • having a pacemaker,
  • body mass index greater than 30,
  • pathologies of the cervical or lumbar region,
  • cervical radiculopathy, thoracic outlet syndrome, malignant conditions,
  • systemic diseases, such as neurological, psychological, cardiovascular or rheumatologic conditions, loss of function due to these diseases,
  • history of surgery on the spine or upper extremities,
  • acute infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, 06230, Turkey (Türkiye)

Location

Study Officials

  • Özlem Ülger, professor

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Spine Health Unit, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

August 1, 2023

Primary Completion

February 29, 2024

Study Completion

February 29, 2024

Last Updated

January 20, 2025

Record last verified: 2024-10

Locations